Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Medicare

I’m as capitalist as they get but Medicare for all is the best hope for US healthcare

With the US government shut down over impending rises to insurance premiums it’s clear the status quo cannot continue

The Guardian - US

$1,000 for a one-hour appointment: why are fees for Australia’s specialist doctors skyrocketing?

Out-of-pocket costs are increasing faster than inflation and population growth – but increasing Medicare rebates might not be a magic bullet

The Guardian - AU

What are my rights when I need to see a specialist doctor – and what if I can’t afford the fee?

Did you know you can ask your GP for an indefinite referral – so you don’t need a new one every year? Or ask to be sent for free to a public hospital clinic? Here are ways to keep costs down

The Guardian - AU

From analysis to the latest developments in health,
read the most diverse news in one place.

Trump’s Budget: What It Means for Your Retirement, by Age

Trump’s proposed budget could reshape retirement for every age group. Find out how it may affect your savings, Social Security and future plans.

GOBankingRates

I'm 61 and need $50,000 for home repairs. Should I borrow given today's rates or take a withdrawal from my $950,000 401(k)?

We asked financial experts for advice.

Kiplinger

Hard Truths on Medicare Dave Ramsey Thinks Every Retiree Should Know

From gaps in coverage to having to enroll even if they don’t want to, many elements of the federal healthcare program can be frustrating.

GOBankingRates

Watch Out for This One Expense ‘Breaking’ Your Retirement, According to 2 Money Experts

It is an expense that everyone will have, but few people have considered how they will cover it during retirement. This six-figure expense could bankrupt you.

GOBankingRates

Read news from The Economist, FT, and more,
with one subscription

The Mulligan Rule of Retirement — Seven Mistakes You Can Fix

Use the Mulligan Rule to undo these seven costly retirement errors. While you can’t go back in time, some retirement choices allow for a “correction shot.”

Kiplinger

‘We’re Just Trying to Get By:’ Families Hit Hard by SNAP Delays

A federal judge in Rhode Island ordered the Trump administration to deliver SNAP payments in full to all of the states by Friday, November 7....

Saving Advice

Social Security’s 2026 Raise Is Official—But Most Seniors Say It Won’t Even Cover Groceries

The Social Security Administration has officially announced the 2026 cost-of-living adjustment (COLA), and while it’s technically a raise, many seniors say it won’t make a...

Saving Advice

8 Hidden Mental Health Benefits Medicare Won’t Advertise

When most people think of Medicare, they picture hospital stays, doctor visits, and prescription drugs. But what often goes unnoticed is how much mental health...

Saving Advice

Trump Unveils 'TrumpRx' Program Slashing Prices of Wegovy and Zepbound

Trump launches "TrumpRx" program to cut prices of Wegovy and Zepbound, making weight-loss drugs more affordable for Americans.

International Business Times

Medigap vs. Medicare Open Enrollment: What's the Difference?

Nearly 10,000 people in America turn 65 every day. Why is that significant? It signals Medicare eligibility and shines a light on Medicare supplement insurance, known as Medigap.

Kiplinger

TrumpRx News: Why Donald Trump Struck a Deal With Novo Nordisk's Weight Loss Drugs — And What It Says About America's Obesity Problem

Certain GLP-1 weight loss medications will be available for as little as $149 per month, a sharp drop from the current average retail price of $1,000–$1,350.

International Business Times UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Eli Lilly Crushed Novo In Obesity Drug Battle—Trump Now Forces Price Cuts

President Donald Trump unveiled a major pricing and coverage deal with drug giants Eli Lilly and Co. (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) on Thursday, pledging to make blockbuster weight-loss drugs like Zepbound and Wegovy significantly cheaper and accessible for millions of Americans.

Barchart

Michael Burry Abandons UnitedHealth Stock With Shares Down 35% YTD. Should You Sell UNH or Buy the Dip?

Down almost 50% from all-time highs, UnitedHealth stock trades at a compelling valuation while offering investors an attractive dividend yield.

Benzinga

Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx

President Donald Trump on Thursday announced agreements with Eli Lilly and Co. (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) to significantly reduce prices for their GLP-1-based obesity and diabetes drugs.

The Guardian - US

Trump announces plan to cut cost of weight loss drugs and expand access

Injectable versions of GLP-1s from Eli Lilly and Novo Nordisk will see reduced prices and broader coverage

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic

America's waistline may shrink, but its national debt will swell.

Budget and the Bees

How to Appeal a Medicare Denial (And Win): A Step-by-Step Guide

You open the mail, and your stomach drops. The Medicare Summary Notice shows a service or item as “Denied.” It’s infuriating and, additionally, very scary. Many people simply give up and pay the bill. However, a denial is *not* the end of the road. You have the right to appeal,…

Axios

Trump says Medicare can now cover weight loss drugs like Ozempic

The pilot program could make it easier for seniors to use drugs like Wegovy and Zepbound.

The Independent UK

Trump announces plans to slim down cost of popular weight-loss drugs to $149 a month

Novo Nordisk and Eli Lilly become latest drug companies to bend knee to Trump’s ‘most-favored nation’ pricing plan

The Independent UK

Trump unveils deal to expand coverage and lower costs on obesity drugs

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy

Saving Advice

Hidden Costs in Medicare Part C That Will Catch Seniors Off-Guard in 2026

What seems like a low-cost alternative to Original Medicare can come with financial surprises. Recent reports show that Medicare Advantage (Part C) enrollees may see...

The Guardian - US

Trump is weaponizing the welfare state to attack healthcare

The proposed withholding of Medicaid and Medicare to restrict gender-affirming care follows the same logic as attacks on abortion care

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

the Social Security Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.